22057 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Hudis
    Hudis
  4. Kris
    Kris
  5. Saltz
    Saltz
  6. Offit
    Offit
  7. O'Reilly
    O'Reilly
  8. Solit
    Solit
  9. Robson
    Robson
  10. Drilon
    Drilon

Groups

  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)
  7. Breast Medicine Service (4103)
  8. Surgery (4019)
  9. Department of Pathology and Laboratory Medicine (3422)
  10. Thoracic Oncology (3351)
  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient selection markers for anti-angiogenic agents in metastatic renal cell carcinoma: Dream or reality?
    Meeting Abstract

    English, P. A.; Williams, J. A.; Martini, J. F.; Motzer, R. J.; Valota, O.; Buller, R. E.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Treating metastatic melanoma with the BRAF inhibitor vemurafenib and mechanisms of resistance
    Meeting Abstract

    Chapman, P.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Effects of radiologic tumor response of anti-glypican-3 GC33 and multi tyrosine kinases inhibitor sorafenib in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Zhao, B.; Chou, J. F.; Ma, J.; Capanu, M.; Koga, M.; Lee, R.; Othomo, T.; Germino, J.; Schwartz, L.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • (124)I GC33 positron emission tomography (PET), imaging biomarker of glypican-3 in hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; O'Donoghue, J. A.; Gansukh, B.; Ma, J.; Ruan, S.; Koga, M.; Lee, R.; Ohishi, N.; Othomo, T.; Carrasquillo, J. A.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: Potential for rapid monitoring of treatment responses
    Journal Article

    Ulmert, D.; Vickers, A. J.; Scher, H. I.; Becker, C.; Iversen, P.; Frankel, D.; Jensen, J. K.; Olesen, T. K.; Lilja, H.
    Clinical Chemistry and Laboratory Medicine (2012)

    Fulltext@MSK | Save
  • Neoadjuvant therapy in clinical stage II pancreatic adenocarcinoma
    Journal Article

    Snyder, A.; Allen, P.; Shamseddine, A.; Haydar, A.; Eloubeidi, M.; Faraj, W.; Khalife, M.; Temraz, S.; El Olayan, A.; Kelsen, D. P.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Ninth annual ISGIO meeting
    Journal Article

    Ilson, D. H.
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Management of a locally advanced rectal cancer in a patient who declined surgery
    Journal Article

    Alameddine, R.; Wehbe, D.; Weiser, M.; Segal, N.; Goodman, K.; Shamseddine, A.; Ang, C.; Haydar, A.; Sidani, M.; Geara, F.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save